SUVENPHAR Suven Pharmaceuticals Ltd Investor Conferences Announcement 2025 - Investor Presentation Suven Pharmaceuticals shared an Investor Presentation for the JPMC Healthcare conference in January 2025, highlighting strong financials with USD 315 million revenue and 37% EBITDA margins, alongside significant industry relationships and capabilities..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Suven Pharmaceuticals Ltd